The Danish respiratory society guideline for long-term high flow nasal cannula treatment, with or without supplementary oxygen

Ulla Møller Weinreich*, Kasper Svendsen Juhl, Malene Søby Christophersen, Svend Gundestrup, Munsoor Ali Hanifa, Kristine Jensen, Frank Dyekjær Andersen, Ole Hilberg, Line Hust Storgaard

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

5 Citations (Scopus)
44 Downloads (Pure)

Abstract

Introduction: Long-term High Flow Nasal Cannula (LT-HFNC), defined as High Flow Nasal Cannula treatment provided to patients with chronic pulmonary conditions during stable phases, has emerged as a home treatment in different categories of patients with chronic lung diseases in recent years. Methods: This paper summarizes the physiological effects of LT-HFNC and evaluates the clinical knowledge to date about treatment in patients with chronic obstructive lung disease, interstitial lung disease and bronchiectasis. The guideline is translated and summarized in this paper and presented unabridged as an appendix to the paper. Results: The paper describes the working process behind the Danish Respiratory Society’s National guideline for treatment of stable disease, which has been written to support clinicians in both evidence-based decision making and practical issues concerning the treatment.

Original languageEnglish
Article number2178600
JournalEuropean Clinical Respiratory Journal
Volume10
Issue number1
ISSN2001-8525
DOIs
Publication statusPublished - 2023

Bibliographical note

© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Keywords

  • Bronchiectasis
  • COPD
  • Chronic obstructive lung disease
  • HFNC
  • HFNO
  • HFOT
  • High Flow Nasal Cannula
  • High flow nasal oxygen
  • High flow oxygen therapy
  • ILD
  • Interstitial lung disease
  • NHF
  • Nasal high flow
  • home treatment
  • long-term treatment

Fingerprint

Dive into the research topics of 'The Danish respiratory society guideline for long-term high flow nasal cannula treatment, with or without supplementary oxygen'. Together they form a unique fingerprint.

Cite this